The WACC of International Biotechnology Trust PLC (IBT.L) is 10.7%.
| Range | Selected | |
| Cost of equity | 9.50% - 13.20% | 11.35% |
| Tax rate | 0.50% - 0.60% | 0.55% |
| Cost of debt | 4.60% - 4.60% | 4.60% |
| WACC | 9.0% - 12.4% | 10.7% |
| Category | Low | High |
| Long-term bond rate | 4.0% | 4.5% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 0.92 | 1.18 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 9.50% | 13.20% |
| Tax rate | 0.50% | 0.60% |
| Debt/Equity ratio | 0.1 | 0.1 |
| Cost of debt | 4.60% | 4.60% |
| After-tax WACC | 9.0% | 12.4% |
| Selected WACC | 10.7% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for IBT.L:
cost_of_equity (11.35%) = risk_free_rate (4.25%) + equity_risk_premium (6.50%) * adjusted_beta (0.92) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.